GlaxoSmithKline PLC Logo

GlaxoSmithKline PLC

ISIN: GB00BN7SWP63 | Ticker: GSK | LEI: 5493000HZTVUYLO1D793

About GlaxoSmithKline PLC

Company Description

We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.

Our R&D focus is on four therapeutic areas: infectious diseases, HIV, immunology/respiratory and oncology

Year founded

2000

Served area

Worldwide

Headcount

69,400

Headquarters

C8 Gsk House, 980 Great West Road, TW8 9GS Brentford – United Kingdom

Filings & Publications

2022

Report Q1 H1 Q3 FY
Consolidated Report ENG
Corporate Governance Report
Company Presentation
General Presentation
Sustainability Report
Remuneration Report

2021

Report Q1 H1 Q3 FY
Consolidated Report ENG
Corporate Governance Report
Company Presentation
General Presentation
Sustainability Report
Remuneration Report

Shareholder information

Shares outstanding

2,001,000,000

IPO

May 22, 1972

Stock exchange(s)

London Stock Exchange

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.